Name: Biodefense Market by Technology (GHz-band Wave, Microwave Heating, RF-EMR, Cold Plasma, Gamma, UV), Product (Decontamination (Sterilization Devices, Disinfection Units), Biosensors, AI Surveillance), Application, Region - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: AS9373
Price: 4950 USD
Availability: InStock

報告摘要

The biodefense market is estimated at USD 0.89 billion in 2025 and is projected to reach USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period. Technological advancements and changing market conditions are the key drivers of the biodefense market. "Based on product, sterilization devices under decontamination is estimated to hold the largest market share in 2025." Based on product, decontamination is categorized into disinfection units and sterilization devices. Sterilization devices are expected to account for the largest market share in 2025 due to their indispensable function in eliminating a broad biological agent in healthcare, defense, and laboratory environments. The growing need for low-temperature sterilizers, hydrogen peroxide vapor systems, microwave sterilizer units, and gamma irradiation solutions has increased the need for organizations to find stable, validated procedures for decontaminating medical equipment, laboratory surfaces, and delicate equipment. These instruments provide high performance, regulatory approval, and compatibility with intricate and heat-sensitive materials, which are critical to biosafety regulations in hospitals, research facilities, and mobile bio-containment units. "Biosensor-based technologies segment is estimated to hold the largest market share in 2025 by technology." Based on technology, biosensor-based technologies are estimated to account for the largest market in the biodefense market by 2025 due to their pivotal function in providing real-time, precise, and decentralized sensing of biological threats. Biosensor-based technologies are being widely used in hospitals, defense forces, border control, and public health organizations for their high sensitivity and quick response to detecting pathogens like anthrax, ricin, and new viruses. The emergence of point-of-care diagnostics and increasing demand for early warning systems in biodefense applications have considerably enhanced the usage of biosensor technologies. Their versatility in varied environments, ranging from military field operations to urban hospitals and mobile laboratories, makes them valuable to the biodefense market. "Europe is estimated to hold the second-largest market share in 2025." Europe is estimated to have the second-largest share of the biodefense market due to growing government efforts to enhance biosecurity and pandemic preparedness. The region has witnessed increased investment in biosurveillance infrastructure and decontamination technologies. Countries such as Germany, France, and the UK are at the forefront with strong public health systems and country-level biodefense strategies. Besides that, robust partnerships among defense agencies, biotech firms, and research organizations have boosted innovation in technologies like mobile biocontainment units, biosensors, and AI-based threat detection. Support from EU-wide initiatives such as Horizon Europe and cooperation with the European Centre for Disease Prevention and Control (ECDC) further boost regional readiness. The break-up of the profile of primary participants in the biodefense market: • By Company Type: Tier 1 – 35%, Tier 2 – 54%, and Tier 3 – 20% • By Designation: Directors– 55%, Managers – 27%, Others – 18% • By Region: North America – 40%, Europe – 20%, Asia Pacific – 30%, Rest of the World – 10% STERIS (US), ASP International GmbH (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the key market players that offer connectivity applicable to various sectors and have well-equipped and strong distribution networks across North America, Europe, Asia Pacific, and the Rest of the World. Research Coverage: The study covers the biodefense market across various segments and subsegments. It aims to estimate the size and growth potential of this market across different segments based on product, application, technology, and region. This study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their solutions and business offerings, recent developments undertaken by them, and key market strategies adopted by them. This report segments the biodefense market across five key regions: North America, Europe, Asia Pacific, and the Rest of the World and their respective key countries. The report's scope includes in-depth information on significant factors, such as drivers, restraints, challenges, and opportunities that influence the growth of the biodefense market. A comprehensive analysis of major industry players has been conducted to provide insights into their business profiles, solutions, and services. This analysis also covers key aspects like agreements, collaborations, product launches, contracts, expansions, acquisitions, and partnerships associated with the biodefense market. Reasons to buy this report: This report serves as a valuable resource for market leaders and newcomers in the biodefense market, offering data that closely approximates revenue figures for both the overall market and its subsegments. It equips stakeholders with a comprehensive understanding of the competitive landscape, facilitating informed decisions to enhance their market positioning and formulating effective go-to-market strategies. The report imparts valuable insights into the market dynamics, offering information on crucial factors such as drivers, restraints, challenges, and opportunities, enabling stakeholders to gauge the market's pulse. The report provides insights into the following pointers: • Analysis of Key Drivers: Rising threat of bioterrorism, high government funding, strategic national stockpiling, and increasing technological advancements • Market Penetration: Comprehensive information on biodefense solutions offered by the top players in the market • Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the biodefense market • Market Development: Comprehensive information about lucrative markets; the report analyses the biodefense market across varied regions • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the biodefense market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players in the biodefense market

目錄 Table of Contents

1 INTRODUCTION 22 1.1 STUDY OBJECTIVES 22 1.2 MARKET DEFINITION 22 1.3 MARKET SCOPE 23 1.3.1 BIODEFENSE MARKET SEGMENTATION 23 1.3.2 YEARS CONSIDERED 23 1.4 CURRENCY AND PRICING 24 1.5 INCLUSIONS AND EXCLUSIONS 24 1.6 STAKEHOLDERS 25 2 RESEARCH METHODOLOGY 26 2.1 RESEARCH DATA 26 2.1.1 SECONDARY DATA 27 2.1.1.1 Key data from secondary sources 28 2.1.2 PRIMARY DATA 28 2.1.2.1 Key primary sources 28 2.1.2.2 Key data from primary sources 29 2.1.2.3 Breakdown of primary interviews 29 2.2 FACTOR ANALYSIS 30 2.2.1 INTRODUCTION 30 2.2.2 DEMAND-SIDE INDICATORS 30 2.2.3 SUPPLY-SIDE INDICATORS 30 2.3 MARKET SIZE ESTIMATION 31 2.3.1 BOTTOM-UP APPROACH 31 2.3.1.1 Company revenue estimation approach 31 2.3.1.2 Growth rate projections 32 2.3.2 TOP-DOWN APPROACH 32 2.3.2.1 Market assessment by region and country 32 2.4 DATA TRIANGULATION 33 2.5 RESEARCH ASSUMPTIONS 34 2.6 RISK ANALYSIS 34 2.7 RESEARCH LIMITATIONS 34 2.7.1 METHODOLOGY-RELATED LIMITATIONS 34 2.7.2 SCOPE-RELATED LIMITATIONS 34 3 EXECUTIVE SUMMARY 35 4 PREMIUM INSIGHTS 38 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BIODEFENSE MARKET 38 4.2 BIODEFENSE MARKET, BY PRODUCT 38 4.3 BIODEFENSE MARKET, BY TECHNOLOGY 39 4.4 BIODEFENSE MARKET, BY APPLICATION 39 4.5 BIODEFENSE MARKET, BY COUNTRY 40 5 MARKET OVERVIEW 41 5.1 INTRODUCTION 41 5.2 MARKET DYNAMICS 41 5.2.1 DRIVERS 42 5.2.1.1 Rising threat of bioterrorism 42 5.2.1.2 Increase in government funding and strategic national stockpiling 42 5.2.1.3 Technological advancements and innovations 43 5.2.1.4 Growing geopolitical tensions and biological warfare risks 44 5.2.2 RESTRAINTS 45 5.2.2.1 High R&D costs and long approval times 45 5.2.2.2 Lack of global standardization in biodefense protocols 45 5.2.3 OPPORTUNITIES 46 5.2.3.1 Emergence of AI-powered biosurveillance & predictive analytics 46 5.2.3.2 Emergence of nanotechnology-based biosensors 46 5.2.4 CHALLENGES 47 5.2.4.1 Infrastructure shortages in low-resource areas 47 5.2.4.2 Cybersecurity risks in connected biodefense systems 47 5.3 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 48 5.4 VALUE CHAIN ANALYSIS 48 5.4.1 RESEARCH & DEVELOPMENT (~10-20%) 49 5.4.2 RAW MATERIAL PRODUCERS (~20-40%) 49 5.4.3 PRODUCT MANUFACTURING (~40-60%) 49 5.4.4 TESTING & QUALITY ASSURANCE (~60-80%) 49 5.4.5 END USERS (~80-100%) 49 5.5 ECOSYSTEM ANALYSIS 49 5.5.1 PROMINENT COMPANIES 49 5.5.2 PRIVATE AND SMALL ENTERPRISES 49 5.5.3 END USERS 50 5.6 TARIFF AND REGULATORY LANDSCAPE 51 5.7 TRADE DATA 53 5.7.1 IMPORT SCENARIO 53 5.7.2 EXPORT SCENARIO 54 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 55 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 56 5.8.2 BUYING CRITERIA 56 5.9 USE CASE ANALYSIS 57 5.9.1 USE CASE 1: REAL-TIME PATHOGEN DETECTION AT TORONTO PEARSON INTERNATIONAL AIRPORT 58 5.9.2 USE CASE 2: US–UK STRATEGIC DIALOGUE ON BIOLOGICAL SECURITY 58 5.9.3 USE CASE 3: ENHANCED REMOTE DETECTION OF AEROSOL AND VAPOR THREATS WITH MX908 BEACON 58 5.10 KEY CONFERENCES AND EVENTS, 2025–2026 59 5.11 PRICING ANALYSIS 59 5.11.1 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION 60 5.11.2 FACTORS IMPACTING COST IN BIODEFENSE MARKET 60 5.11.3 INDICATIVE PRICING ANALYSIS OF BIODEFENSE TECHNOLOGIES, BY KEY PLAYERS, 2025 63 5.12 INVESTMENT AND FUNDING SCENARIO 63 5.13 IMPACT OF AI/ GENERATIVE AI ON BIODEFENSE MARKET 64 5.13.1 PREDICTIVE BIOSURVEILLANCE 65 5.13.2 NEXT-GENERATION BIOSENSORS 65 5.13.3 RAPID PATHOGEN IDENTIFICATION 65 5.13.4 IMAGE & SIGNAL ANALYSIS 65 5.13.5 SYNTHETIC DATA GENERATION 65 5.14 MACROECONOMIC OUTLOOK 65 5.14.1 INTRODUCTION 65 5.14.2 NORTH AMERICA 66 5.14.3 EUROPE 66 5.14.4 ASIA PACIFIC 66 5.14.5 MIDDLE EAST 66 5.14.6 LATIN AMERICA 67 5.14.7 AFRICA 67 5.15 BUSINESS MODELS 67 5.15.1 BUSINESS MODELS IN BIODEFENSE MARKET 67 5.16 TECHNOLOGY ROADMAP 68 6 INDUSTRY TRENDS 70 6.1 INTRODUCTION 70 6.2 TECHNOLOGY TRENDS 70 6.2.1 NANOTECHNOLOGY-ENABLED BIOSENSORS 70 6.2.2 DIGITAL HEALTH TOOLS & MOBILE BIOSURVEILLANCE 71 6.2.3 REMOTE SENSING FOR DETECTION AND IDENTIFICATION OF BIOLOGICAL THREATS 71 6.2.4 DIGITAL TWINS & SIMULATION TECHNOLOGY 72 6.3 IMPACT OF MEGATRENDS 72 6.3.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR BIOTHREAT DETECTION 72 6.3.2 BLOCKCHAIN FOR SUPPLY CHAIN AND DATA INTEGRITY 73 6.4 TECHNOLOGY ANALYSIS 73 6.4.1 KEY TECHNOLOGIES 73 6.4.1.1 Real-time aerosol detectors 73 6.4.1.2 Mass spectrometry 73 6.4.2 COMPLEMENTARY TECHNOLOGIES 74 6.4.2.1 Decision support systems 74 6.4.2.2 Geospatial information systems 74 6.4.3 ADJACENT TECHNOLOGIES 75 6.4.3.1 High-throughput screening 75 6.4.3.2 Digital identity and biometric authentication 75 6.5 PATENT ANALYSIS 76 7 BIODEFENSE MARKET, BY PRODUCT 79 7.1 INTRODUCTION 80 7.2 DETECTION & SURVEILLANCE 81 7.2.1 INCREASING THREAT OF EMERGING INFECTIOUS DISEASES AND BIOTERRORISM TO DRIVE SEGMENTAL GROWTH 81 7.2.2 BIOSENSOR SYSTEMS 82 7.2.3 AI-BASED PLATFORMS 83 7.3 DECONTAMINATION SYSTEMS 84 7.3.1 RISING GOVERNMENT AND DEFENSE SECTOR INVESTMENTS IN BIOSECURITY INFRASTRUCTURE TO DRIVE SEGMENTAL GROWTH 84 7.3.2 DISINFECTION UNITS 84 7.3.3 STERILIZATION DEVICES 86 7.4 OTHERS 87 7.4.1 PURIFICATION UNITS 88 7.4.2 CONTAINMENT & ISOLATION DEVICES 89 8 BIODEFENSE MARKET, BY TECHNOLOGY 91 8.1 INTRODUCTION 92 8.2 GHZ-BAND WAVE EMISSION FOR AIRBORNE VIRAL INACTIVATION 93 8.2.1 CHEMICAL-FREE AND RAPID DECONTAMINATION FEATURE TO DRIVE GROWTH 93 8.3 UV-BASED TECHNOLOGIES 94 8.3.1 GROWING NEED TO REDUCE SPREAD OF AIRBORNE OR SURFACE-DEPOSITED PATHOGENS IN HIGH-RISK AREAS TO DRIVE GROWTH 94 8.4 MICROWAVE HEATING 95 8.4.1 ABILITY TO QUICKLY DISINFECT CONFINED SPACES OR CRITICAL SURFACES EXPOSED TO AIRBORNE BIOTERROR AGENTS TO DRIVE GROWTH 95 8.5 RADIOFREQUENCY (RF-EMR) HEATING 96 8.5.1 STERILIZATION AND DISINFECTION APPLICATIONS TO DRIVE GROWTH 96 8.6 COLD PLASMA-BASED PATHOGEN INACTIVATION 97 8.6.1 BROAD-SPECTRUM PATHOGEN INACTIVATION TO DRIVE GROWTH 97 8.7 GAMMA RADIATION 98 8.7.1 LONG-RANGE AND HIGH-VOLUME APPLICATION TO DRIVE GROWTH 98 8.8 BIOSENSOR TECHNOLOGIES 99 8.8.1 IMMEDIATE THREAT IDENTIFICATION WITHOUT FULL LABORATORY SUPPORT TO DRIVE GROWTH 99 8.8.1.1 Electrochemical biosensors 99 8.8.1.2 Optical biosensors 99 8.8.1.3 Piezoelectric biosensors 99 8.8.1.4 Thermal biosensors 99 8.8.1.5 Nanomechanical biosensors 100 8.9 AI TECHNOLOGIES 100 8.9.1 ABILITY TO PREDICT OUTBREAKS AND IDENTIFY EMERGING THREATS IN REAL TIME TO DRIVE GROWTH 100 8.9.1.1 Machine learning for outbreak prediction 100 8.9.1.2 AI integration with surveillance networks 101 8.10 OTHERS 101 9 BIODEFENSE MARKET, BY APPLICATION 103 9.1 INTRODUCTION 104 9.2 MILITARY 105 9.2.1 THREAT OF BIOLOGICAL WARFARE TO DRIVE DEMAND 105 9.3 HOMELAND SECURITY 105 9.3.1 INCREASING NEED FOR DETECTION AND EARLY WARNING BIODEFENSE SYSTEMS TO DRIVE DEMAND 105 9.4 PUBLIC INFRASTRUCTURE 106 9.4.1 HIGH NEED FOR SAFEGUARDING CITIZENS AND ENSURING RESILIENCE IN FACE OF BIOLOGICAL RISKS TO DRIVE DEMAND 106 9.5 HOSPITALS & MEDICAL INSTITUTES 106 9.5.1 GROWING NEED FOR HEALTHCARE SYSTEM RESILIENCE TO DRIVE DEMAND 106 9.6 OTHERS 106 10 BIODEFENSE MARKET, BY REGION 107 10.1 INTRODUCTION 108 10.2 NORTH AMERICA 109 10.2.1 PESTLE ANALYSIS 109 10.2.2 US 113 10.2.2.1 Rise in global geopolitical tensions due to concerns about bioterrorism and state-sponsored biological programs to drive market 113 10.2.3 CANADA 114 10.2.3.1 Government's focus on enhancing public health infrastructure to drive market 114 10.3 ASIA PACIFIC 115 10.3.1 PESTLE ANALYSIS 116 10.3.2 INDIA 120 10.3.2.1 Growing national security concerns considering strained relations with neighboring countries to drive market 120 10.3.3 AUSTRALIA 121 10.3.3.1 Increasing government initiatives and investments to drive market 121 10.3.4 CHINA 122 10.3.4.1 Focus on strengthening biosecurity and strategic biotechnology development to drive market 122 10.3.5 JAPAN 124 10.3.5.1 Heightened awareness of biological threats to drive market 124 10.3.6 REST OF ASIA PACIFIC 125 10.4 EUROPE 126 10.4.1 PESTLE ANALYSIS 126 10.4.2 GERMANY 131 10.4.2.1 Comprehensive biosecurity programs and institutional collaboration to drive market 131 10.4.3 UK 132 10.4.3.1 Growing focus on biosurveillance to drive market 132 10.4.4 FRANCE 133 10.4.4.1 Increasing government investment in bioproduction infrastructure and public health preparedness to drive market 133 10.4.5 ITALY 134 10.4.5.1 Increasing focus on building biodefense infrastructure to drive market 134 10.4.6 REST OF EUROPE 136 10.5 REST OF THE WORLD (ROW) 137 10.5.1 PESTLE ANALYSIS 137 10.5.2 MIDDLE EAST & AFRICA 142 10.5.2.1 Increasing need for preparedness for emerging biological threats to drive market 142 10.5.3 LATIN AMERICA 143 10.5.3.1 International collaborations to strengthen national biodefense efforts to drive market 143 11 COMPETITIVE LANDSCAPE 145 11.1 INTRODUCTION 145 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025 145 11.3 BIODEFENSE MARKET REVENUE ANALYSIS, 2020–2025 146 11.4 BIODEFENSE MARKET SHARE ANALYSIS, 2024 147 11.5 BIODEFENSE MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 149 11.5.1 STARS 149 11.5.2 EMERGING LEADERS 149 11.5.3 PERVASIVE PLAYERS 149 11.5.4 PARTICIPANTS 150 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 151 11.5.5.1 Company footprint 151 11.5.5.2 Product footprint 151 11.5.5.3 Technology footprint 152 11.5.5.4 Application footprint 153 11.5.5.5 Region footprint 153 11.6 BIODEFENSE MARKET COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 154 11.6.1 PROGRESSIVE COMPANIES 154 11.6.2 RESPONSIVE COMPANIES 154 11.6.3 DYNAMIC COMPANIES 154 11.6.4 STARTING BLOCKS 154 11.6.5 COMPETITIVE BENCHMARKING 156 11.6.5.1 List of startups/SMEs 156 11.6.5.2 Competitive benchmarking of startups/SMEs 157 11.7 BRAND/PRODUCT COMPARISON 158 11.8 COMPANY VALUATION AND FINANCIAL METRICS 159 11.9 COMPETITIVE SCENARIO 160 11.9.1 DEALS 160 11.9.2 OTHER DEVELOPMENTS 163 12 COMPANY PROFILES 164 12.1 KEY PLAYERS 164 12.1.1 STERIS 164 12.1.1.1 Business overview 164 12.1.1.2 Products offered 165 12.1.1.3 Recent developments 166 12.1.1.3.1 Deals 166 12.1.1.4 MnM view 166 12.1.1.4.1 Key strengths 166 12.1.1.4.2 Strategic choices 166 12.1.1.4.3 Weaknesses and competitive threats 166 12.1.2 ASP INTERNATIONAL GMBH 167 12.1.2.1 Business overview 167 12.1.2.2 Products offered 168 12.1.2.3 MnM view 169 12.1.2.3.1 Key strengths 169 12.1.2.3.2 Strategic choices 169 12.1.2.3.3 Weaknesses and competitive threats 169 12.1.3 USHIO INC. 170 12.1.3.1 Business overview 170 12.1.3.2 Products offered 171 12.1.3.3 Recent developments 172 12.1.3.3.1 Deals 172 12.1.3.4 MnM view 172 12.1.3.4.1 Key strengths 172 12.1.3.4.2 Strategic choices 172 12.1.3.4.3 Weaknesses and competitive threats 172 12.1.4 SOTERA HEALTH COMPANY 173 12.1.4.1 Business overview 173 12.1.4.2 Products offered 174 12.1.4.3 MnM view 175 12.1.4.3.1 Key strengths 175 12.1.4.3.2 Strategic choices 175 12.1.4.3.3 Weaknesses and competitive threats 175 12.1.5 BIOQUELL, AN ECOLAB SOLUTION 176 12.1.5.1 Business overview 176 12.1.5.2 Products offered 177 12.1.5.3 MnM view 178 12.1.5.3.1 Key strengths 178 12.1.5.3.2 Strategic choices 178 12.1.5.3.3 Weaknesses and competitive threats 178 12.1.6 THERMO FISHER SCIENTIFIC INC. 179 12.1.6.1 Business overview 179 12.1.6.2 Products offered 180 12.1.6.3 Recent developments 181 12.1.6.3.1 Deals 181 12.1.7 SMITHS DETECTION GROUP LTD 182 12.1.7.1 Business overview 182 12.1.7.2 Products offered 182 12.1.7.3 Recent developments 183 12.1.7.3.1 Deals 183 12.1.8 E4LIFE SRL. 184 12.1.8.1 Business overview 184 12.1.8.2 Products offered 184 12.1.9 SYNEXIS 185 12.1.9.1 Business overview 185 12.1.9.2 Products offered 185 12.1.9.3 Recent developments 186 12.1.9.3.1 Deals 186 12.1.10 BLUEDOT INC. 187 12.1.10.1 Business overview 187 12.1.10.2 Products offered 187 12.1.10.3 Recent developments 188 12.1.10.3.1 Deals 188 12.1.11 XENEX DISINFECTION SERVICES INC. 189 12.1.11.1 Business overview 189 12.1.11.2 Products offered 189 12.1.11.3 Recent developments 190 12.1.11.3.1 Other developments 190 12.1.12 SKAN AG 191 12.1.12.1 Business overview 191 12.1.12.2 Products offered 192 12.1.12.3 Recent developments 192 12.1.12.3.1 Deals 192 12.1.13 MICROSOFT 193 12.1.13.1 Business overview 193 12.1.13.2 Products offered 194 12.1.14 BIO-RAD LABORATORIES, INC. 195 12.1.14.1 Business overview 195 12.1.14.2 Products offered 196 12.1.15 AIRBOSS DEFENSE GROUP, INC. 197 12.1.15.1 Business overview 197 12.1.15.2 Products offered 198 12.1.15.3 Recent developments 198 12.1.15.3.1 Deals 198 12.2 OTHER PLAYERS 199 12.2.1 IONISOS 199 12.2.2 AQUISENSE 199 12.2.3 GERMFREE 200 12.2.4 PATHOGENFOCUS 201 12.2.5 UV LIGHT TECHNOLOGY LTD – PART OF DARO GROUP 202 12.2.6 BERTIN TECHNOLOGIES 203 12.2.7 FAR UV TECHNOLOGIES, INC. 203 12.2.8 PURE AQUA, INC. 204 12.2.9 PALANTIR TECHNOLOGIES INC. 205 12.2.10 PÜSCHNER MICROWAVE POWER SYSTEMS 206 13 APPENDIX 207 13.1 DISCUSSION GUIDE 207 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 209 13.3 CUSTOMIZATION OPTIONS 211 13.4 RELATED REPORTS 211 13.5 COMPANY LONG LIST 213 13.6 AUTHOR DETAILS 217

圖表清單 List of Tables & Figures

TABLE 1 USD EXCHANGE RATES, 2019–2024 24 TABLE 2 BIODEFENSE MARKET: INCLUSIONS AND EXCLUSIONS 24 TABLE 3 IMPACT OF TECHNOLOGICAL ADVANCEMENTS ON BIODEFENSE MARKET: COMPARISON OF TRADITIONAL VS. MODERN APPROACHES 43 TABLE 4 ROLE OF COMPANIES IN ECOSYSTEM 50 TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 51 TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 52 TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 52 TABLE 8 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 53 TABLE 9 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 54 TABLE 10 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 55 TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TOP 3 APPLICATIONS (%) 56 TABLE 12 KEY BUYING CRITERIA, BY TOP 3 APPLICATIONS 57 TABLE 13 KEY CONFERENCES AND EVENTS, 2025–2026 59 TABLE 14 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION, 2024 (USD) 60 TABLE 15 INDICATIVE PRICING OF BIODEFENSE TECHNOLOGIES, BY KEY PLAYERS, 2025 63 TABLE 16 COMPARISON BETWEEN DIFFERENT BUSINESS MODELS 68 TABLE 17 LIST OF MAJOR PATENTS FOR BIODEFENSE, 2023–2025 77 TABLE 18 BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 80 TABLE 19 BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 81 TABLE 20 BIODEFENSE MARKET FOR DETECTION & SURVEILLANCE PRODUCT TYPES, 2021–2024 (USD MILLION) 81 TABLE 21 BIODEFENSE MARKET FOR DETECTION & SURVEILLANCE PRODUCT TYPES, 2025–2030 (USD MILLION) 81 TABLE 22 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY BIOSENSOR PRODUCT TYPE, 2021–2024 (USD MILLION) 82 TABLE 23 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY BIOSENSOR PRODUCT TYPE, 2025–2030 (USD MILLION) 82 TABLE 24 SMITH DETECTION GROUP LTD: BIOFLASH BIOLOGICAL IDENTIFIER: SPECIFICATIONS 82 TABLE 25 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY AI-BASED PLATFORM TYPE, 2021–2024 (USD MILLION) 83 TABLE 26 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY AI-BASED PLATFORM TYPE, 2025–2030 (USD MILLION) 83 TABLE 27 KRAKEN SENSE PRODUCT: KRAKEN™ PATHOGEN RISK DETECTION SYSTEM: SPECIFICATIONS 83 TABLE 28 BIODEFENSE MARKET, BY DECONTAMINATION SYSTEM TYPE, 2021–2024 (USD MILLION) 84 TABLE 29 BIODEFENSE MARKET, BY DECONTAMINATION SYSTEM TYPE, 2025–2030 (USD MILLION) 84 TABLE 30 BIODEFENSE DISINFECTION UNITS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 85 TABLE 31 BIODEFENSE DISINFECTION UNITS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 85 TABLE 32 DRDO PRODUCT: UV BLASTER–AREA UV DISINFECTION SYSTEM: SPECIFICATIONS 85 TABLE 33 BIODEFENSE STERILIZATION DEVICES MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 86 TABLE 34 BIODEFENSE STERILIZATION DEVICES MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 86 TABLE 35 STERIS PLC PRODUCT: STERIS VHP M100 BIODECONTAMINATION UNIT: SPECIFICATIONS 87 TABLE 36 BIODEFENSE MARKET, BY OTHER PRODUCTS, 2021–2024 (USD MILLION) 87 TABLE 37 BIODEFENSE MARKET, BY OTHER PRODUCTS, 2025–2030 (USD MILLION) 87 TABLE 38 BIODEFENSE PURIFICATION UNITS MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 88 TABLE 39 BIODEFENSE PURIFICATION UNITS MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 88 TABLE 40 CASTELLEX PRODUCT: AIR 40 BIO FILTRATION UNIT WITH UV LIGHT: SPECIFICATIONS 89 TABLE 41 BIODEFENSE CONTAINMENT & ISOLATION DEVICES MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 90 TABLE 42 BIODEFENSE CONTAINMENT & ISOLATION DEVICES MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 90 TABLE 43 EPIGUARD PRODUCT: EPISHUTTLE–MEDICAL ISOLATION AND TRANSPORT UNIT: SPECIFICATIONS 90 TABLE 44 BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 92 TABLE 45 BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 93 TABLE 46 BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 104 TABLE 47 BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 105 TABLE 48 BIODEFENSE MARKET, BY REGION, 2021–2024 (USD MILLION) 108 TABLE 49 BIODEFENSE MARKET, BY REGION, 2025–2030 (USD MILLION) 109 TABLE 50 NORTH AMERICA: BIODEFENSE MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 111 TABLE 51 NORTH AMERICA: BIODEFENSE MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 111 TABLE 52 NORTH AMERICA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 111 TABLE 53 NORTH AMERICA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 111 TABLE 54 NORTH AMERICA: BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 112 TABLE 55 NORTH AMERICA: BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 112 TABLE 56 NORTH AMERICA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 112 TABLE 57 NORTH AMERICA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 113 TABLE 58 US: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 113 TABLE 59 US: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 113 TABLE 60 US: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 114 TABLE 61 US: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 114 TABLE 62 CANADA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 114 TABLE 63 CANADA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 115 TABLE 64 CANADA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 115 TABLE 65 CANADA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 115 TABLE 66 ASIA PACIFIC: BIODEFENSE MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 118 TABLE 67 ASIA PACIFIC: BIODEFENSE MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 118 TABLE 68 ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 118 TABLE 69 ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 118 TABLE 70 ASIA PACIFIC: BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 119 TABLE 71 ASIA PACIFIC: BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 119 TABLE 72 ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 119 TABLE 73 ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 120 TABLE 74 INDIA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 120 TABLE 75 INDIA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 120 TABLE 76 INDIA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 121 TABLE 77 INDIA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 121 TABLE 78 AUSTRALIA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 121 TABLE 79 AUSTRALIA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 122 TABLE 80 AUSTRALIA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 122 TABLE 81 AUSTRALIA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 122 TABLE 82 CHINA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 123 TABLE 83 CHINA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 123 TABLE 84 CHINA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 123 TABLE 85 CHINA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 123 TABLE 86 JAPAN: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 124 TABLE 87 JAPAN: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 124 TABLE 88 JAPAN: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 124 TABLE 89 JAPAN: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 125 TABLE 90 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 125 TABLE 91 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 125 TABLE 92 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 126 TABLE 93 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 126 TABLE 94 EUROPE: BIODEFENSE MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 128 TABLE 95 EUROPE: BIODEFENSE MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 129 TABLE 96 EUROPE: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 129 TABLE 97 EUROPE: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 129 TABLE 98 EUROPE: BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 129 TABLE 99 EUROPE: BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 130 TABLE 100 EUROPE: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 130 TABLE 101 EUROPE: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 130 TABLE 102 GERMANY: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 131 TABLE 103 GERMANY: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 131 TABLE 104 GERMANY: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 131 TABLE 105 GERMANY: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 132 TABLE 106 UK: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 132 TABLE 107 UK: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 132 TABLE 108 UK: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 133 TABLE 109 UK: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 133 TABLE 110 FRANCE: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 133 TABLE 111 FRANCE: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 134 TABLE 112 FRANCE: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 134 TABLE 113 FRANCE: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134 TABLE 114 ITALY: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 135 TABLE 115 ITALY: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 135 TABLE 116 ITALY: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 135 TABLE 117 ITALY: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 135 TABLE 118 REST OF EUROPE: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 136 TABLE 119 REST OF EUROPE: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 136 TABLE 120 REST OF EUROPE: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 136 TABLE 121 REST OF EUROPE: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 137 TABLE 122 REST OF THE WORLD: BIODEFENSE MARKET, BY REGION, 2021–2024 (USD MILLION) 139 TABLE 123 REST OF THE WORLD: BIODEFENSE MARKET, BY REGION, 2025–2030 (USD MILLION) 139 TABLE 124 REST OF THE WORLD: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 140 TABLE 125 REST OF THE WORLD: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 140 TABLE 126 REST OF THE WORLD: BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 140 TABLE 127 REST OF THE WORLD: BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 141 TABLE 128 REST OF THE WORLD: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 141 TABLE 129 REST OF THE WORLD: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 141 TABLE 130 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 142 TABLE 131 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 142 TABLE 132 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION 143 TABLE 133 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 143 TABLE 134 LATIN AMERICA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 143 TABLE 135 LATIN AMERICA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 144 TABLE 136 LATIN AMERICA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 144 TABLE 137 LATIN AMERICA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 144 TABLE 138 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025 145 TABLE 139 BIODEFENSE MARKET: DEGREE OF COMPETITION 147 TABLE 140 BIODEFENSE MARKET: PRODUCT FOOTPRINT 151 TABLE 141 BIODEFENSE MARKET: TECHNOLOGY FOOTPRINT 152 TABLE 142 BIODEFENSE MARKET: APPLICATION FOOTPRINT 153 TABLE 143 BIODEFENSE MARKET: REGION FOOTPRINT 153 TABLE 144 BIODEFENSE MARKET: LIST OF STARTUPS/SMES 156 TABLE 145 BIODEFENSE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 157 TABLE 146 BIODEFENSE MARKET: DEALS, 2020–2025 160 TABLE 147 BIODEFENSE MARKET: OTHER DEVELOPMENTS, 2020–2025 163 TABLE 148 STERIS: COMPANY OVERVIEW 164 TABLE 149 STERIS: PRODUCTS OFFERED 165 TABLE 150 STERIS: DEALS 166 TABLE 151 ASP INTERNATIONAL GMBH: COMPANY OVERVIEW 167 TABLE 152 ASP INTERNATIONAL GMBH: PRODUCTS OFFERED 168 TABLE 153 USHIO INC.: COMPANY OVERVIEW 170 TABLE 154 USHIO INC.: PRODUCTS OFFERED 171 TABLE 155 USHIO INC.: DEALS 172 TABLE 156 SOTERA HEALTH COMPANY: COMPANY OVERVIEW 173 TABLE 157 SOTERA HEALTH COMPANY: PRODUCTS OFFERED 174 TABLE 158 BIOQUELL, AN ECOLAB SOLUTION: COMPANY OVERVIEW 176 TABLE 159 BIOQUELL, AN ECOLAB SOLUTION: PRODUCTS OFFERED 177 TABLE 160 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 179 TABLE 161 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 180 TABLE 162 THERMO FISHER SCIENTIFIC INC.: DEALS 181 TABLE 163 SMITHS DETECTION GROUP LTD: COMPANY OVERVIEW 182 TABLE 164 SMITHS DETECTION GROUP LTD: PRODUCTS OFFERED 182 TABLE 165 SMITHS DETECTION GROUP LTD: DEALS 183 TABLE 166 E4LIFE SRL.: COMPANY OVERVIEW 184 TABLE 167 E4LIFE SRL.: PRODUCTS OFFERED 184 TABLE 168 SYNEXIS: COMPANY OVERVIEW 185 TABLE 169 SYNEXIS: PRODUCTS OFFERED 185 TABLE 170 SYNEXIS: DEALS 186 TABLE 171 BLUEDOT INC.: COMPANY OVERVIEW 187 TABLE 172 BLUEDOT INC.: PRODUCTS OFFERED 187 TABLE 173 BLUEDOT INC.: DEALS 188 TABLE 174 XENEX DISINFECTION SERVICES INC.: COMPANY OVERVIEW 189 TABLE 175 XENEX DISINFECTION SERVICES INC.: PRODUCTS OFFERED 189 TABLE 176 XENEX DISINFECTION SERVICES INC.: OTHER DEVELOPMENTS 190 TABLE 177 SKAN AG: COMPANY OVERVIEW 191 TABLE 178 SKAN AG: PRODUCTS OFFERED 192 TABLE 179 SKAN AG : DEALS 192 TABLE 180 MICROSOFT: COMPANY OVERVIEW 193 TABLE 181 MICROSOFT: PRODUCTS OFFERED 194 TABLE 182 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 195 TABLE 183 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 196 TABLE 184 AIRBOSS DEFENSE GROUP, INC.: COMPANY OVERVIEW 197 TABLE 185 AIRBOSS DEFENSE GROUP, INC.: PRODUCTS OFFERED 198 TABLE 186 AIRBOSS DEFENSE GROUP, INC.: DEALS 198 TABLE 187 IONISOS: COMPANY OVERVIEW 199 TABLE 188 AQUISENSE: COMPANY OVERVIEW 199 TABLE 189 GERMFREE: COMPANY OVERVIEW 200 TABLE 190 PATHOGENFOCUS: COMPANY OVERVIEW 201 TABLE 191 UV LIGHT TECHNOLOGY LTD – PART OF DARO GROUP: COMPANY OVERVIEW 202 TABLE 192 BERTIN TECHNOLOGIES: COMPANY OVERVIEW 203 TABLE 193 FAR UV TECHNOLOGIES, INC.: COMPANY OVERVIEW 203 TABLE 194 PURE AQUA, INC.: COMPANY OVERVIEW 204 TABLE 195 PALANTIR TECHNOLOGIES INC.: COMPANY OVERVIEW 205 TABLE 196 PÜSCHNER MICROWAVE POWER SYSTEMS: COMPANY OVERVIEW 206 FIGURE 1 RESEARCH PROCESS FLOW 26 FIGURE 2 BIODEFENSE MARKET: RESEARCH DESIGN 27 FIGURE 3 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 31 FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 32 FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 32 FIGURE 6 DATA TRIANGULATION 33 FIGURE 7 DECONTAMINATION SYSTEMS TO BE LEADING PRODUCT SEGMENT OF BIODEFENSE MARKET IN 2030 35 FIGURE 8 AI TECHNOLOGIES TO REGISTER DECENT CAGR DURING FORECAST PERIOD 36 FIGURE 9 HOSPITALS & MEDICAL INSTITUTES TO BE LEADING APPLICATION OF BIODEFENSE IN 2025 36 FIGURE 10 NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF BIODEFENSE MARKET IN 2025 37 FIGURE 11 INCREASING ADVANCEMENTS IN BIODEFENSE TECHNOLOGIES TO DRIVE GROWTH 38 FIGURE 12 DECONTAMINATION SYSTEMS SEGMENT TO LEAD BIODEFENSE MARKET IN 2025 38 FIGURE 13 AI TECHNOLOGIES SEGMENT TO LEAD BIODEFENSE MARKET IN 2025 39 FIGURE 14 HOSPITALS & MEDICAL INSTITUTES SEGMENT TO LEAD BIODEFENSE MARKET IN 2025 39 FIGURE 15 AUSTRALIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40 FIGURE 16 BIODEFENSE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41 FIGURE 17 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 48 FIGURE 18 VALUE CHAIN ANALYSIS 48 FIGURE 19 ECOSYSTEM ANALYSIS 50 FIGURE 20 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 54 FIGURE 21 EXPORT DATA FOR HS CODE 901890, 2020–2024 (USD THOUSAND) 55 FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TOP 3 APPLICATIONS 56 FIGURE 23 KEY BUYING CRITERIA, BY TOP 3 APPLICATIONS 57 FIGURE 24 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION 60 FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2020–2024 64 FIGURE 26 BIODEFENSE MARKET: IMPACT OF AI/GEN AI 64 FIGURE 27 BUSINESS MODELS IN BIODEFENSE MARKET 67 FIGURE 28 EVOLUTION OF TECHNOLOGY IN BIODEFENSE MARKET 68 FIGURE 29 TECHNOLOGY ROADMAP 69 FIGURE 30 LIST OF MAJOR PATENTS RELATED TO BIODEFENSE, 2014–2025 76 FIGURE 31 DECONTAMINATION SYSTEMS SEGMENT TO LEAD BIODEFENSE MARKET DURING FORECAST PERIOD 80 FIGURE 32 AI TECHNOLOGIES SEGMENT TO LEAD BIODEFENSE MARKET IN 2030 92 FIGURE 33 HOSPITALS & MEDICAL INSTITUTES SEGMENT TO LEAD BIODEFENSE MARKET DURING FORECAST PERIOD 104 FIGURE 34 BIODEFENSE MARKET, BY REGION, 2025–2030 108 FIGURE 35 NORTH AMERICA: BIODEFENSE MARKET SNAPSHOT 110 FIGURE 36 ASIA PACIFIC: BIODEFENSE MARKET SNAPSHOT 117 FIGURE 37 EUROPE: BIODEFENSE MARKET SNAPSHOT 128 FIGURE 38 REST OF THE WORLD: BIODEFENSE MARKET SNAPSHOT 139 FIGURE 39 BIODEFENSE MARKET REVENUE ANALYSIS OF TOP 5 PLAYERS, 2021–2024 (USD MILLION) 146 FIGURE 40 BIODEFENSE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 147 FIGURE 41 BIODEFENSE MARKET COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 150 FIGURE 42 BIODEFENSE MARKET: COMPANY FOOTPRINT 151 FIGURE 43 BIODEFENSE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 155 FIGURE 44 BRAND/PRODUCT COMPARISON 158 FIGURE 45 FINANCIAL METRICS OF PROMINENT MARKET PLAYERS 159 FIGURE 46 VALUATION OF PROMINENT MARKET PLAYERS 159 FIGURE 47 STERIS: COMPANY SNAPSHOT 165 FIGURE 48 ASP INTERNATIONAL GMBH: COMPANY SNAPSHOT 168 FIGURE 49 USHIO INC.: COMPANY SNAPSHOT 171 FIGURE 50 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT 174 FIGURE 51 BIOQUELL, AN ECOLAB SOLUTION: COMPANY SNAPSHOT 177 FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 180 FIGURE 53 SKAN AG: COMPANY SNAPSHOT 191 FIGURE 54 MICROSOFT: COMPANY SNAPSHOT 194 FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 196 FIGURE 56 AIRBOSS DEFENSE GROUP, INC.: COMPANY SNAPSHOT 197

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Biodefense Market by Technology (GHz-band Wave, Microwave Heating, RF-EMR, Cold Plasma, Gamma, UV), Product (Decontamination (Sterilization Devices, Disinfection Units), Biosensors, AI Surveillance), Application, Region - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（航太與國防）